Sumeet Bagadia advises buying dips above 25,800 and recommends five breakout stocks for intraday trading opportunities.

My name is Zafar Aziz from the Deutsche Bank team. I'm pleased to announce our next presentation will be from AstraZeneca from the U.K. Before I show our speaker, a few points to note. Please submit ...

Besides stomach cancer, the FDA also raised a similar concern for PD-1 drugs in first-line esophageal squamous cell carcinoma ...

Renal cancer, also known as kidney cancer, is a disease where malignant (cancer) cells form in the tissues of the kidneys. Smoking, obesity, hypertension, and chronic kidney disease contribute to ...

The newly launched “What Science Can Do” campaign, a longstanding tagline for AstraZeneca, centers around the stories of two patients who have benefitted from the company’s therapeutics. Each of their ...

Linde India: The Supreme Court rejected Linde India's appeal against a Securities and Exchange Board of India (SEBI) ...

Daiichi Sankyo and AstraZeneca saw a dip in stock prices after announcing that their Phase III TROPION-Breast01 trial for ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

The Nifty Pharma index closed on a positive note on Tuesday. Shares of Mankind Pharma Ltd.(up 3.18 per cent), Ipca ...

Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...

Astrazeneca Pharma India Ltd registered volume of 10.98 lakh shares by 14:14 IST on NSE, a 166.41 fold spurt over two-week average daily volume of 6599 shares ...